Relation of body mass index to mortality among Asian patients with obstructive coronary artery disease during a 10-year follow-up: A report from the ET-CHD registry

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 616-620

  Lin, Gen Min ^a,b   Li, Yi Hwei ^a   Lin, Chin Lon ^c   Wang, Ji Hung ^c   Han, Chih Lu ^d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b HUALIEN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Body mass index; Coronary artery bypass grafting; Obesity mortality paradox; Obstructive coronary artery disease; Percutaneous coronary intervention

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ASIAN; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME; UNDERWEIGHT;

BODY MASS INDEX; CORONARY ARTERY BYPASS GRAFTING; OBESITY-MORTALITY PARADOX; OBSTRUCTIVE CORONARY ARTERY DISEASE; PERCUTANEOUS CORONARY INTERVENTION;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COHORT STUDIES; CORONARY ARTERY DISEASE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; REGISTRIES; RESEARCH REPORT; SURVIVAL RATE; TIME FACTORS;

EID: 84883769753     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.204     Document Type: Article

References (38)

1. K.R. Fontaine, D.T. Redden, C. Wang, A.O. Westfall, and D.B. Allison Years of life lost due to obesity JAMA 289 2003 187 193
2. S. Klein, L.E. Burke, and G.A. Bray Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation Circulation 110 2004 2952 2967
3. A. Oreopoulos, R. Padwal, K. Kalantar-Zadeh, G.C. Fonarow, C.M. Norris, and F.A. McAlister Body mass index and mortality in heart failure: a meta-analysis Am Heart J 156 2008 13 22
4. A.O. Badheka, A. Rathod, and M.A. Kizilbash Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox Am J Med 123 2010 646 651
5. K. Kalantar-Zadeh, G. Block, T. Howich, and G.C. Fonarow Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure J Am Coll Cardiol 43 2004 1439 1444
6. M.R. Carnethon, P.J. De Chavez, and M.L. Biggs Association of weight status with mortality in adults with incident diabetes JAMA 308 2012 581 590
7. S.G. Ellis, J. Elliott, M. Horrigan, R.E. Raymond, and G. Howell Lownormal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention Am J Cardiol 78 1996 642 646
8. H.S. Gurm, P.L. Whitlow, K.E. Kip, and BARI Investigators The impact of body mass index on short- and long-term outcomes in patients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI) J Am Coll Cardiol 39 2002 834 840
9. L. Gruberg, N. Mercado, and S. Milo Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: the obesity paradox II? Am J Cardiol 95 2005 439 444
10. A. Romero-Corral, V.M. Montori, and V.K. Somers Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies Lancet 368 2006 666 677
11. A. Oreopoulos, F.A. McAlister, and K. Kalantar-Zadeh The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from approach Eur Heart J 30 2009 2584 2592
12. O. Angerås, P. Albertsson, and K. Karason Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry Eur Heart J 34 5 Feb 2013 345 353
13. A. Oreopoulos, R. Padwal, C.M. Norris, J.C. Mullen, V. Pretorius, and K. Kalantar-Zadeh Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis Obesity (Silver Spring) 16 2008 442 450
14. B.D. Powell, R.J. Lennon, and A. Lerman Association of body mass index with outcome after percutaneous coronary intervention Am J Cardiol 91 2003 472 476
15. L. Gruberg, N.J. Weissman, and R. Waksman The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39 2002 578 584
16. M. Kosuge, K. Kimura, and S. Kojima Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction Circ J 72 2008 521 525
17. W.Y. Kang, M.H. Jeong, and Y.K. Ahn Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction J Cardiol 55 2010 84 91
18. S.H. Sung, T.C. Wu, C.H. Huang, S.J. Lin, and J.W. Chen Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery Heart 97 2011 648 654
19. I. Akin, R. Tölg, and M. Hochadel No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry JACC Cardiovasc Interv 5 2012 162 169
20. G. Sarno, L. Räber, and Y. Onuma Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents Am J Cardiol 108 2011 195 201
21. G.M. Lin, Y.H. Li, and N.C. Zheng Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997-2003 J Cardiol 61 2 Feb 2013 122 127
22. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 2004 157 163
23. T. Ivert, K. Huttunen, C. Landou, and V.O. Björk Angiographic studies of internal mammary artery grafts 11 years after coronary artery bypass grafting J Thorac Cardiovasc Surg 96 1988 1 12
24. K.W. Mahaffey, S.T. Tonev, and S.A. Spinler Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial Int J Cardiol 139 2010 123 133
25. M. Schmiegelow, C. Torp-Pedersen, and G.H. Gislason Relation of body mass index to risk of stent thrombosis after percutaneous coronary intervention Am J Cardiol 110 2012 1592 1597
26. M.B. Kadakia, C.S. Fox, B.M. Scirica, S.A. Murphy, M.P. Bonaca, and D.A. Morrow Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial Heart 97 2011 1782 1787
27. T. Lancefield, D.J. Clark, and N. Andrianopoulos Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry JACC Cardiovasc Interv 3 2010 660 668
28. J.O. Younge, N.L. Damen, R.T. van Domburg, and S.S. Pedersen Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox Int J Cardiol 167 4 Aug 20 2013 1154 1158
29. M. Benderly, V. Boyko, and U. Goldbourt Relation of body mass index to mortality among men with coronary heart disease Am J Cardiol 106 2010 297 304
30. R.P. Wildman, P. Muntner, and K. Reynolds The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US Population (NHANES 1999-2004) Arch Intern Med 168 2008 1617 1624
31. H. Florez, and S. Castillo-Florez Beyond the obesity paradox in diabetes: fitness, fatness, and mortality JAMA 308 2012 619 620
32. M. Zamboni, G. Mazzali, and E. Zoico Health consequences of obesity in the elderly Int J Obes (Lond) 29 2005 1011 1029
33. K. Lee Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors Asia Pac J Clin Nutr 18 2009 280 284
34. R. Tsukinoki, Y. Murakami, and R. Huxley Does body mass index impact on the relationship between systolic blood pressure and cardiovascular disease?: meta-analysis of 419,488 individuals from the Asia pacific cohort studies collaboration Stroke 43 2012 1478 1483
35. P.M. Ridker, E. Danielson, and F.A. Fonseca Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
36. G.M. Lin, K.M. Chu, and C.L. Han Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation models Int J Cardiol 146 2011 422 423
37. C. Willi, P. Bodenmann, W.A. Ghali, P.D. Faris, and J. Cornuz Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis JAMA 298 2007 2654 2664
38. L. Schenkeveld, M. Magro, and R.M. Oemrawsingh The influence of optimal medical treatment on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study BMJ Open 2 2012 e000535